13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details

Clinical trials : 3,342 /  Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

  
1 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04749667
(ClinicalTrials.gov)		August 9, 202120/1/2021Study of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple SclerosisStudy of Mesenchymal Autologous Stem Cells as Regenerative Treatment for Multiple SclerosisMultiple Sclerosis;Progressive Multiple SclerosisOther: MSCs;Drug: SalineHaukeland University HospitalUniversity of Bergen;University Hospital Ulm;University Hospital, Akershus;St. Olavs Hospital;University Hospital of North NorwayRecruiting18 Years55 YearsAll18Phase 1/Phase 2Norway